Segura, AG, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Bioque, M, Cuesta, MJ, Gonzalez-Penas, J, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan, A, Vista, E, Castro-Fornieles, J, Mane, A, Saiz, J, Bernardo, M, Mas, S. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort. SCHIZOPHRENIA RESEARCH. 2022; 244DOI:10.1016/j.schres.2022.05.021. PMID:35659654. IF:4.500(Q2/4D).

Alvear, D, Soler, J, Cebolla, A. Meditators' Non-academic Definition of Mindfulness. Mindfulness. 2022; 13(6)DOI:10.1007/s12671-022-01899-3. PMID:35634214. IF:3.600(Q2/4D).

Bioque, M, Mezquida, G, Amoretti, S, Garcia-Rizo, C, Lopez-Ilundain, JM, Diaz-Caneja, CM, Zorrilla, I, Mane, A, Rodriguez-Jimenez, R, Corripio, I, Pomarol-Clotet, E, Ibanez, A, Usall, J, Contreras, F, Mas, S, Vazquez-Bourgon, J, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Hidalgo-Figueroa, M, Bernardo, M. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2022; 243DOI:10.1016/j.schres.2022.02.026. PMID:35231832. IF:4.500(Q2/4D).

Porta-Casteras, D, Cano, M, Steward, T, Andero, R, Cardoner, N. The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli. Neurobiology of Stress. 2022; 18DOI:10.1016/j.ynstr.2022.100448. PMID:35685680. IF:5.000(Q2/3D).

Rodriguez, N, Gasso, P, Martinez-Pinteno, A, Segura, AG, Mezquida, G, Moreno-Izco, L, Gonzalez-Penas, J, Zorrilla, I, Martin, M, Rodriguez-Jimenez, R, Corripio, I, Sarro, S, Ibanez, A, Butjosa, A, Contreras, F, Bioque, M, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Mas, S, Amoretti, SS, Moren, C, Stella, C, Gurriaran, X, Alonso-Solis, A, Grasa, E, Fernandez, J, Gonzalez-Ortega, I, Casanovas, F, Bulbuena, A, Nunez-Doyle, A, Jimenez-Rodriguez, O, Pomarol-Clotet, E, Feria-Raposo, I, Usall, J, Munoz-Samons, D, Ilundain, JL, Sanchez-Torres, AM, Saiz-Ruiz, J, Lopez-Torres, I, Nacher, J, De-la-Camara, C, Gutierrez, M, Saiz, PA. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00215-1. PMID:35853879. IF:5.400(Q2/3D).

Martínez-Pinteño A., Mezquida G., Bioque M., López-Ilundain J.M., Andreu-Bernabeu Á., Zorrilla I., Mané A., Rodríguez-Jiménez R., Corripio I., Sarró S., Ibáñez Á., Usall J., Rivero O., Gassó P., Leza J.C., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Mas S., Bernardo M., Amoretti S., Morén C., Urbiola E., González-Peñas J., Roldán A., Catalán A., González-Ortega I., Toll A., Legido T., Sanchez-Pastor L., Dompablo M., Pomarol-Clotet E., R L.-R., Butjosa A., Rubio E., Lorente-OmeñacaR, Ribeiro M., López-Torres I., León-Quismondo L., Nácher J., Contretas F., Lobo A., Gutiérrez-Fraile M., Sáiz P.A.. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5.600(Q1/2D).

Wierenga L.M., Doucet G.E., Dima D., Agartz I., Aghajani M., Akudjedu T.N., Albajes-Eizagirre A., Alnæs D., Alpert K.I., Andreassen O.A., Anticevic A., Asherson P., Banaschewski T., Bargallo N., Baumeister S., Baur-Streubel R., Bertolino A., Bonvino A., Boomsma D.I., Borgwardt S., Bourque J., den Braber A., Brandeis D., Breier A., Brodaty H., Brouwer R.M., Buitelaar J.K., Busatto G.F., Calhoun V.D., Canales-Rodríguez E.J., Cannon D.M., Caseras X., Castellanos F.X., Chaim-Avancini T.M., Ching C.R.K., Clark V.P., Conrod P.J., Conzelmann A., Crivello F., Davey C.G., Dickie E.W., Ehrlich S., van't Ent D., Fisher S.E., Fouche J.-P., Franke B., Fuentes-Claramonte P., de Geus E.J.C., Giorgio A.D., Glahn D.C., Gotlib I.H., Grabe H.J., Gruber O., Gruner P., Gur R.E., Gur R.C., Gurholt T.P., de Haan L., Haatveit B., Harrison B.J., Hartman C.A., Hatton S.N., Heslenfeld D.J., van den Heuvel O.A., Hickie I.B., Hoekstra P.J., Hohmann S., Holmes A.J., Hoogman M., Hosten N., Howells F.M., Hulshoff Pol H.E., Huyser C., Jahanshad N., James A.C., Jiang J., Jönsson E.G., Joska J.A., Kalnin A.J., Klein M., Koenders L., Kolskår K.K., Krämer B., Kuntsi J., Lagopoulos J., Lazaro L., Lebedeva I.S., Lee P.H., Lochner C., Machielsen M.W.J., Maingault S., Martin N.G., Martínez-Zalacaín I., Mataix-Cols D., Mazoyer B., McDonald B.C., McDonald C., McIntosh A.M., McMahon K.L., McPhilemy G., van der Meer D., Menchón J.M., Naaijen J., Nyberg L., Oosterlaan J., Paloyelis Y., Pauli P., Pergola G., Pomarol-Clotet E., Portella M.J., Radua J., Reif A., Richard G., Roffman J.L., Rosa P.G.P., Sacchet M.D., Sachdev P.S., Salvador R., Sarró S., Satterthwaite T.D., Saykin A.J., Serpa M.H., Sim K., Simmons A., Smoller J.W., Sommer I.E., Soriano-Mas C., Stein D.J., Strike L.T., Szeszko P.R., Temmingh H.S., Thomopoulos S.I., Tomyshev A.S., Trollor J.N., Uhlmann A., Veer I.M., Veltman D.J., Voineskos A., Völzke H., Walter H., Wang L., Wang Y., Weber B., Wen W., West J.D., Westlye L.T., Whalley H.C., Williams S.C.R., Wittfeld K., Wolf D.H., Wright M.J., Yoncheva Y.N., Zanetti M.V., Ziegler G.C., de Zubicaray G.I., Thompson P.M., Crone E.A., Frangou S., Tamnes C.K.. Greater male than female variability in regional brain structure across the lifespan. HUMAN BRAIN MAPPING. 2022; 43(1)DOI:10.1002/hbm.25204. PMID:33044802. IF:4.800(Q1/2D).

Lorente-Rovira E., Grasa E., Ochoa S., Corripio I., Peláez T., López-Carrilero R., Gutiérrez-Gea Á., Morano-Guillén M., Villagrán J.M., Bartels-Velthuis A.A., Jenner J.A., Sanjuán J.. Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI). SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2022; 15(4)DOI:10.1016/j.rpsm.2020.03.002. PMID:32493672. IF:9.200(Q1/1D).

Perez-Rando, M, Elvira, UKA, Garcia-Marti, G, Gadea, M, Aguilar, EJ, Escarti, MJ, Ahullo-Fuster, MA, Grasa, E, Corripio, I, Sanjuan, J, Nacher, J. Alterations in the volume of thalamic nuclei in patients with schizophrenia and persistent auditory hallucinations. NeuroImage-Clinical. 2022; 35DOI:10.1016/j.nicl.2022.103070. PMID:35667173. IF:4.200(Q2/3D).

Safont G., Garriga M., Amoretti S., Cuesta M.J., Parellada M., González-Pinto A., Bergé D., Rodriguez-Jimenez R., Bejarano A.R., Sarró S., Ibáñez Á., Usall J., Gutiérrez M., Vieta E., Arranz B., Berrocoso E., Verdolini N., Bernardo M.. Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(2)DOI:10.1016/j.rpsm.2022.03.002. PMID:. IF:2.800(Q2/4D).

Espinosa, V, Bagaeva, A, Lopez-Carrilero, R, Barajas, A, Barrigón, ML, Birulés, I, Frigola-Capell, E, Díaz-Cutraro, L, González-Higueras, F, Grasa, E, Gutiérrez-Zotes, A, Lorente-Rovira, E, Pélaez, T, Pousa, E, Ruiz-Delgado, I, Verdaguer-Rodríguez, M, Ochoa, S. Neuropsychological profiles in first-episodes psychosis and their relationship with clinical, metacognition and social cognition variables. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(3)DOI:10.1007/s00406-024-01813-z. PMID:38806850. IF:3.700(Q1/3D).

Miquel-Giner N., Vicent-Gil M., Martínez-Zalacaín I., Porta-Casteras D., Mar L., López-Solà M., Andrews-Hanna J.R., Soriano-Mas C., Menchón J.M., Cardoner N., Alonso P., Serra-Blasco M., López-Solà C.. Efficacy and fMRI-based response predictors to mindfulness-based cognitive therapy in obsessive-compulsive disorder: Study protocol for a randomised clinical trial. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2025; 18(1)DOI:10.1016/j.rpsm.2022.11.002. PMID:37839958. IF:2.800(Q1/1D).

Soler, J, Otero, D, Elices, M, Farres, CC, Vera, J, Pascual, JC. Exploring direct experience as a core element behind mindfulness-based cognitive therapy. EUROPEAN JOURNAL OF PSYCHIATRY. 2024; 38(4)DOI:10.1016/j.ejpsy.2024.100268. PMID:. IF:1.500(Q3/7D).

Pousa, E, Brébion, G, López-Carrilero, R, Ruiz, AI, Grasa, E, Barajas, A, Cobo, J, Gutiérrez-Zotes, A, Lorente, E, Barrigón, ML, Ruiz-Delgado, I, González-Higueras, F, Frigola-Capell, E, Ochoa, S. Predictors of clinical insight in first-episode psychosis: Different patterns in men and women. PSYCHIATRY RESEARCH. 2024; 339DOI:10.1016/j.psychres.2024.116036. PMID:38964140. IF:3.900(Q1/2D).

González-Saiz, F, Vergara-Moragues, E, Trujols, J, Alcaraz, S, de los Cobos, JP. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient. INTERNATIONAL JOURNAL OF DRUG POLICY. 2024; 130DOI:10.1016/j.drugpo.2024.104519. PMID:39024687. IF:4.400(Q1/1D).

Clougher, D, Forte, MF, Mezquida, G, Sánchez-Torres, AM, Serra-Navarro, M, Penadés, R, Lobo, A, Pinto, AG, Panadero, R, Roldán, A, Vieta, E, de la Serna, E, Trabsa, A, Martínez-Aran, A, Torrent, C, Tortorella, A, Menculini, G, Ramos-Quiroga, JA, Cuesta, MJ, Bernardo, M, Amoretti, S. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 85DOI:10.1016/j.euroneuro.2024.05.006. PMID:39013243. IF:6.700(Q1/1D).

Corripio, I, Fraguas, D, García-Portilla, MP, Olivares, JM, Sierra, P, Sánchez, P. Functioning in schizophrenia: Recommendations of an expert panel. SCHIZOPHRENIA RESEARCH. 2024; 270DOI:10.1016/j.schres.2024.06.050. PMID:38964076. IF:3.500(Q1/3D).

Florido, A, Velasco, ER, Romero, LR, Acharya, N, Blasco, IJM, Nabás, JF, Perez-Caballero, L, Rivero, G, Olabarrieta, E, Nuñez-delMoral, A, González-Parra, JA, Porta-Casteràs, D, Cano, M, Steward, T, Antony, MS, Cardoner, N, Torrubia, R, Jackson, AC, Fullana, MA, Andero, R. Sex differences in neural projections of fear memory processing in mice and humans. Science Advances. 2024; 10(28)DOI:10.1126/sciadv.adk3365. PMID:38985873. IF:12.500(Q1/1D).

Porta-Casteràs, D, Vicent-Gil, M, Serra-Blasco, M, Navarra-Ventura, G, Solé, B, Montejo, L, Torrent, C, Martinez-Aran, A, de la Peña-Arteaga, V, Palao, D, Vieta, E, Cardoner, N, Cano, M. Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2024; 132DOI:10.1016/j.pnpbp.2024.110962. PMID:38365103. IF:3.900(Q1/2D).

Camacho-Téllez, V, Castro, MN, Wainsztein, AE, Goldberg, X, De Pino, G, Costanzo, EY, Cardoner, N, Menchón, JM, Soriano-Mas, C, Guinjoan, SM, Villarreal, MF. Childhood adversity modulates structural brain changes in borderline personality but not in major depression disorder. PSYCHIATRY RESEARCH-NEUROIMAGING. 2024; 340DOI:10.1016/j.pscychresns.2024.111803. PMID:38460393. IF:2.100(Q1/1D).

De la Peña-Arteaga, V, Chavarría-Elizondo, P, Juaneda-Seguí, A, Martínez-Zalacaín, I, Morgado, P, Menchón, JM, Picó-Pérez, M, Fullana, MA, Soriano-Mas, C. Trait anxiety is associated with attentional brain networks. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 83DOI:10.1016/j.euroneuro.2024.02.013. PMID:38492550. IF:6.700(Q1/1D).

Almodóvar-Payá, C, Guardiola-Ripoll, M, Giralt-López, M, Oscoz-Irurozqui, M, Canales-Rodríguez, EJ, Madre, M, Soler-Vidal, J, Ramiro, N, Callado, LF, Arias, B, Gallego, C, Pomarol-Clotet, E, Fatjó-Vilas, M. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia. Brain Structure & Function. 2024; 229(5)DOI:10.1007/s00429-024-02793-5. PMID:38720004. IF:2.900(Q1/1D).

Gracia-Liso, R, Portella, MJ, Pujals-Altes, E, Punti-Vidal, J, Llorens, M, Pamias, M, Jimenez, MF, Aguirrezabala, IM, Palao, DJ. Comparing frequencies of adolescent suicide attempters pre- and during COVID-19 pandemic school terms. BMC Psychiatry. 2024; 24(1)DOI:10.1186/s12888-024-05823-y. PMID:38760731. IF:3.600(Q1/3D).

Palazón-Llecha, A, Caparrós, B, Trujols, J, Duran-Sindreu, S, Batlle, F, Madre, M, Mallorquí-Bagué, N. Predictors of cocaine use disorder treatment outcomes: a systematic review. Systematic Reviews. 2024; 13(1)DOI:10.1186/s13643-024-02550-z. PMID:38720357. IF:3.900(Q1/2D).

de Girolamo, G, Andreassen, OA, Bauer, M, Brambilla, P, Calza, S, Citera, N, Corcoy, R, Fagiolini, A, Garcia-Argibay, M, Godin, O, Klingler, F, Kobayashi, NF, Larsson, H, Leboyer, M, Matura, S, Martinelli, A, de la Pena-arteaga, V, Poli, R, Reif, A, Ritter, P, Rodevand, LN, Magno, M, Caselani, E, Bayas, M, Bellivier, F, Alvarez, NC, Carmellini, P, Cevoli, F, Clemens, J, Courtet, P, Consoli, L, Delvecchio, G, Dobrosavljevic, M, Etain, B, Friedrichsen, H, Kelemen, A, Koukouna, D, Mato, E, Mauricio, D, Miranda-Olivos, R, Moebius, L, Moltrasio, C, Mohn-Haugen, C, Nuss, I, Olie, E, Pelletier, A, Rahman, Z, Rampi, D, Repple, J, Resmini, E, Schneider, J, Toffol, E. Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol. International Journal of Bipolar Disorders. 2024; 12(1)DOI:10.1186/s40345-024-00337-8. PMID:38703295. IF:3.500(Q1/3D).

Garcia-Marti G., Escarti M.J., Nacher J., Perez-Rando M., Mane A., Usall J., Berrocoso E., Pomarol-Clotet E., Lopez-Ilundain J.M., Cuesta M.J., Rodriguez-Jimenez R., Gonzalez-Pinto A., Mar L., Ibañez A., Roldan A., Janssen J., Parellada M., Amoretti S., Bernardo M., Sanjuan J., Aguilar E.J.. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations. SCHIZOPHRENIA RESEARCH. 2024; 267DOI:10.1016/j.schres.2023.11.011. PMID:38044223. IF:3.500(Q1/3D).

Llorca-Bofí, V, Madero, S, Amoretti, S, Cuesta, MJ, Moreno, C, González-Pinto, A, Bergé, D, Rodriguez-Jimenez, R, Roldán, A, García-León, MA, Ibáñez, A, Usall, J, Contreras, F, Mezquida, G, García-Rizo, C, Berrocoso, E, Bernardo, M, Bioque, M. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2024; 267DOI:10.1016/j.schres.2024.03.011. PMID:38513331. IF:3.500(Q1/3D).

de la Pena-arteaga, V, Cano, M, Porta-Casteras, D, Vicent-Gil, M, Miquel-Giner, N, Martinez-Zalacain, I, Mar-Barrutia, L, Lopez-Sola, M, Andrews-Hanna, JR, Soriano-Mas, C, Alonso, P, Serra-Blasco, M, Lopez-Sola, C, Cardoner, N. Mindfulness-based cognitive therapy neurobiology in treatment-resistant obsessive-compulsive disorder: A domain-related resting-state networks approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 82DOI:10.1016/j.euroneuro.2024.02.011. PMID:38503084. IF:6.700(Q1/1D).

Casellas-Pujol, E, Soler, J, Schmidt, C, Soriano, J, Pascual, JC. Long-lasting symptoms in borderline personality disorder: Defining an emergent population with differential clinical and therapeutic features. Personality and Mental Health. 2024; 18(3)DOI:10.1002/pmh.1614. PMID:38666509. IF:2.700(Q2/4D).

Perez-Rando, M, García-Martí, G, Escarti, MJ, Salgado-Pineda, P, McKenna, PJ, Pomarol-Clotet, E, Grasa, E, Postiguillo, A, Corripio, I, Nacher, J. Alterations in the volume and shape of the basal ganglia and thalamus in schizophrenia with auditory hallucinations. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2024; 131DOI:10.1016/j.pnpbp.2024.110960. PMID:38325744. IF:3.900(Q1/2D).

Alvarez-Tomás, I, Soler, J, Schmidt, C, Pascual, JC. Physical health, primary care utilization and long-term quality of life in borderline personality disorder: A 10-year follow-up study in a Spanish sample. JOURNAL OF PSYCHOSOMATIC RESEARCH. 2024; 179DOI:10.1016/j.jpsychores.2024.111623. PMID:38422718. IF:3.300(Q2/3D).

Schmidt, C, Soler, J, Vega, D, Pascual, JC. Practice matters: The role of mindfulness skills in emotion dysregulation in borderline personality disorder. Journal of Contextual Behavioral Science. 2024; 32DOI:10.1016/j.jcbs.2024.100756. PMID:. IF:3.000(Q1/3D).

Casanovas, F, Dinamarca, F, Oller, S, Trabsa, A, Martínez-Sadurní, L, Rodríguez-Seoane, R, Zabaleta, N, Martin, LM, Perez-Sola, V, Ruiz, AI. Differences in clinical variables of cervical cancer in women with schizophrenia. EUROPEAN PSYCHIATRY. 2024; 67DOI:. PMID:. IF:6.700(Q1/1D).

Schmidt, C, Nicolaou, S, Pascual, JC, Punti, J, Lara, A, Sintes, A, Méndez, I, Romero, S, Briones-Buixassa, L, Santamarina-Perez, P, Soler, J, Vega, D. Identifying High-Risk Subgroups of College Students with Non-Suicidal Self-Injury: A Latent Profile Analysis and Two-Years Follow-up Study. JOURNAL OF YOUTH AND ADOLESCENCE. 2024; 53(6)DOI:10.1007/s10964-024-01970-3. PMID:38553580. IF:3.600(Q1/3D).

Ochoa, S, Espinosa, V, López-Carrilero, R, Martinez, I, Barrera, AD, Birulés, I, Barajas, A, Pélaez, T, Díaz-Cutraro, L, Coromina, M, González-Rodríguez, A, Verdaguer-Rodríguez, M, Gutiérrez-Zotes, A, Palma-Sevillano, C, Montes, C, Gallego, J, Paya, B, Casanovas, F, Roldán, M, Noval, E, Casals, PV, Salas-Sender, M, Aznar, A, Ayesa-Arriola, R, Pousa, E, Canal-Rivero, M, Garrido-Torres, N, Montserrat, C, Muñoz-Lorenzo, L, Crosas, JM. Effectiveness of family metacognitive training in mothers with psychosis and their adolescent children: a multicenter study protocol. Frontiers in Psychology. 2024; 15DOI:10.3389/fpsyg.2024.1359693. PMID:38586292. IF:2.900(Q1/3D).

Triola, M, Cobo, J, González-Rodríguez, A, Nieto, L, Ochoa, S, Usall, J, García-Ribera, C, Baños, I, González, B, Solanilla, A, Massons, C, Ruiz, I, Ruiz, AI, Oliva, JC, Pousa, E. Impact of Delusions and Hallucinations on Clinical Insight Dimensions in Schizophrenia Spectrum Disorders. PSYCHOPATHOLOGY. 2024; 57(4)DOI:10.1159/000536360. PMID:38442692. IF:2.200(Q3/6D).

Martín-Blanco, A, González-Fernández, A, Farré, A, Sagué-Vilavella, M, Vieira, S, Giménez, D, Alvaro, P, Isern, C, Torres, C, de la Cruz, V, Martín, C, Moll, N, Portella, MJ. A Change of Paradigm in the Management of Acute Psychiatric Episodes? A Retrospective Cohort Study on Trajectories of Use of Clinical Resources After the Implementation of Intensive Home-Treatment. COMMUNITY MENTAL HEALTH JOURNAL. 2024; 60(5)DOI:10.1007/s10597-024-01236-z. PMID:38424398. IF:1.700(Q3/7D).

Espinosa, V, Naides, N, López-Carrilero, R, Vila-Badia, R, Colomer-Salvans, A, Barajas, A, Barrigón, ML, Birulés, I, Butjosa, A, Díaz-Cutraro, L, Del Cacho, N, Frigola-Capell, E, González-Higueras, F, Grasa, E, Gutiérrez-Zotes, A, Lorente-Rovira, E, Moreno-Kustner, B, Pélaez, T, Pousa, E, Ruiz-Delgado, I, Serra-Arumí, C, Verdaguer-Rodríguez, M, Grp Profep Spanish Metacognition Grp, Usall, J, Ochoa, S. The influence of gender in cognitive insight and cognitive bias in people with first-episode psychosis: an uncontrolled exploratory analysis. Archives of Womens Mental Health. 2024; 27(5)DOI:10.1007/s00737-024-01425-5. PMID:38353751. IF:2.700(Q2/4D).

Portella M.J., González-González I., Jubero M., Trujols J., Pérez V.. Depressive-Like Effects of Foreclosing: A Cross-Sectional Study of Hair Cortisol Concentration. PSYCHOPATHOLOGY. 2024; 57(1)DOI:10.1159/000530706. PMID:37331349. IF:2.200(Q3/6D).

Espinosa, V, Arin-González, P, Jimenez-Lafuente, A, Pardo, N, López-Carrilero, R, Birulés, I, Barajas, A, Pélaez, T, Díaz-Cutraro, L, Verdaguer-Rodríguez, M, Gutiérrez-Zotes, A, Palma-Sevillano, C, Varela-Casals, P, Salas-Sender, M, Aznar, A, Ayesa-Arriola, R, Pousa, E, Canal-Rivero, M, Garrido-Torres, N, Montserrat, C, Muñoz-Lorenzo, L, Crosas, JM, Ochoa, S. Family Metacognitive Training (MCT-F): Adapting MCT to Mothers with Psychosis and Their Adolescent Children. Behavioral Sciences. 2024; 14(2)DOI:10.3390/bs14020097. PMID:38392450. IF:2.500(Q2/3D).

Rosa, N, Feliu, A, Ballbè, M, Alaustre, L, Vilalta, E, Torres, N, Nieva, G, Pla, M, Pinet, C, Raich, A, Mondon, S, Barrio, P, Andreu, M, Suelves, JM, Vilaplana, J, Enríquez, M, Castellano, Y, Guydish, J, Fernández, E, Martínez, C. Quitline nurses' experiences in providing telephone-based smoking cessation help to mental health patients: A mixed methods study. Journal of Psychiatric and Mental Health Nursing. 2024; DOI:10.1111/jpm.13012. PMID:38288784. IF:2.900(Q1/2D).

Efthimiou O., Taipale H., Radua J., Schneider-Thoma J., Pinzón-Espinosa J., Ortuño M., Vinkers C.H., Mittendorfer-Rutz E., Cardoner N., Tanskanen A., Fusar-Poli P., Cipriani A., Vieta E., Leucht S., Tiihonen J., Luykx J.J.. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. LANCET PSYCHIATRY. 2024; 11(2)DOI:10.1016/S2215-0366(23)00366-8. PMID:38215784. IF:24.800(Q1/1D).

Clougher D., Segura A.G., Forte M.F., Mezquida G., Cuesta M.J., Vieta E., Amoretti S., Lobo A., González-Pinto A., Díaz-Caneja C.M., Roldán A., Fico G., De La Serna E., Bergé D., Gassó P., Rodriguez N., Verdolini N., Tortorella A., Menculini G., Ribasés M., Bernardo M., Mas S.. The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysis. EUROPEAN PSYCHIATRY. 2024; DOI:10.1192/j.eurpsy.2023.2480. PMID:. IF:(Q/D).

Argyelan, M, Deng, ZD, Ousdal, OT, Oltedal, L, Angulo, B, Baradits, M, Spitzberg, AJ, Kessler, U, Sartorius, A, Dols, A, Narr, KL, Espinoza, R, van Waarde, JA, Tendolkar, I, van Eijndhoven, P, van Wingen, GA, Takamiya, A, Kishimoto, T, Jorgensen, MB, Jorgensen, A, Paulson, OB, Yrondi, A, Péran, P, Soriano-Mas, C, Cardoner, N, Cano, M, van Diermen, L, Schrijvers, D, Belge, JB, Emsell, L, Bouckaert, F, Vandenbulcke, M, Kiebs, M, Hurlemann, R, Mulders, PCR, Redlich, R, Dannlowski, U, Kavakbasi, E, Kritzer, MD, Ellard, KK, Camprodon, JA, Petrides, G, Malhotra, AK, Abbott, CC. Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression (NOV, 10.1038/s41380-023-02318-2, 2023). MOLECULAR PSYCHIATRY. 2023; DOI:10.1038/s41380-023-02358-8. PMID:38052984. IF:9.600(Q1/1D).

Alcantarilla, L, López-Castro, M, Betriu, M, Torres, A, Garcia, C, Solé, E, Gelabert, E, Roca-Lecumberri, A. Risk factors for relapse or recurrence in women with bipolar disorder and recurrent major depressive disorder in the perinatal period: a systematic review. Archives of Womens Mental Health. 2023; 26(6)DOI:10.1007/s00737-023-01370-9. PMID:37718376. IF:3.200(Q2/4D).

Mezquida G., Amoretti S., Bioque M., García-Rizo C., Sánchez-Torres A.M., Pina-Camacho L., Lopez-Pena P., Mané A., Rodriguez-Jimenez R., Corripio I., Sarró S., Ibañez A., Usall J., García-Portilla M.P., Vieta E., Mas S., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M.. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2023; 16(3)DOI:10.1016/j.rpsm.2023.01.004. PMID:37716849. IF:9.200(Q/D).

Vicent-Gil, M, Trujols, J, Serra-Blasco, M, Navarra-Ventura, G, Puigdemont, D, Alemany, C, Crivillés, S, de Diego-Adeliño, J, Cardoner, N, Portella, MJ. If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression. EUROPEAN PSYCHIATRY. 2023; 66(1)DOI:10.1192/j.eurpsy.2023.2454. PMID:37855104. IF:7.200(Q1/1D).

Contreras-Rodriguez, O, Reales-Moreno, M, Fernandez-Barres, S, Cimpean, A, Arnoriaga-Rodriguez, M, Puig, J, Biarnes, C, Motger-Alberti, A, Cano, M, Fernandez-Real, JM. Consumption of ultra-processed foods is associated with depression, mesocorticolimbic volume, and inflammation. JOURNAL OF AFFECTIVE DISORDERS. 2023; 335DOI:10.1016/j.jad.2023.05.009. PMID:37207947. IF:4.900(Q1/2D).

Fagiolini A., Cardoner N., Pirildar S., Ittsakul P., Ng B., Duailibi K., El Hindy N.. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. EXPERT OPINION ON PHARMACOTHERAPY. 2023; 24(15)DOI:10.1080/14656566.2023.2242264. PMID:37501324. IF:2.500(Q3/6D).

Mateo-Canedo, C, Sanabria-Mazo, JP, Comendador, L, Rojas, JS, Carmona, M, Crespo-Puig, N, Anyosa, F, Selva, C, Feliu-Soler, A, Cardoner, N, Deus, J, Luciano, JV, Mendez-Ulrich, JL, Sanz, A. Predictive factors of hesitancy to vaccination against SARS-CoV-2 virus in young adults in Spain: Results from the PSY-COVID study. Vaccine: X. 2023; 14DOI:10.1016/j.jvacx.2023.100301. PMID:37091731. IF:(Q/D).

Grasa E., Corripio I., Peris-Baquero O., Roldán A., Selma J., Osma J.. Opening Treatment Windows for Treatment-Resistant Schizophrenia: Improving Emotion Regulation Strategies Using the Unified Protocol in a Case Study in Spain. Clinical Case Studies. 2023; DOI:10.1177/15346501231190912. PMID:. IF:0.800(Q4/9D).

Cano, M, Lee, E, Polanco, C, Barbour, T, Ellard, KK, Andreou, B, Uribe, S, Henry, ME, Seiner, S, Cardoner, N, Soriano-Mas, C, Camprodon, JA. Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression. JOURNAL OF AFFECTIVE DISORDERS. 2023; 333DOI:10.1016/j.jad.2023.03.093. PMID:37024015. IF:4.900(Q1/2D).

Oteo-Álvaro Á., García C.G., Sánchez A.I., Santamaria C.A., de Diego-Adeliño J.. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10)DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4.200(Q1/3D).

Goodman-Casanova J.M., Cuesta-Lozano D., Alupoaei C., Bello, EMG, Herrera-Imbroda J., Mayoral-Cleries F., Guzman-Parra J.. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:2.600(Q2/3D).

Arca, G, Nunez, C, Stephan-Otto, C, Arnaez, J, Agut, T, Cordeiro, M, Boronat, N, Lubian-Lopez, S, Benavente-Fernandez, I, Valverde, E, Garcia-Alix, A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3.200(Q1/2D).

Segura, AG, Mane, A, Prohens, L, Rodriguez, N, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Diaz-Caneja, CM, Bejarano, AR, Jimenez, E, Baeza, I, Legido, T, Saiz-Ruiz, J, Bernardo, M, Mas, S. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. PSYCHIATRY RESEARCH. 2023; 325DOI:10.1016/j.psychres.2023.115249. PMID:37178502. IF:4.200(Q1/2D).

Serra-Navarro M., Amoretti S., Verdolini N., Forte M.F., Sánchez-Torres A.M., Vieta E., Clougher D., Lobo A., González-Pinto A., Panadero R., Roldán A., Carvalho A.F., de la Serna E., Toll A., Ramos-Quiroga J.A., Torrent C., Cuesta M.J., Bernardo M., PEPs Grp. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (vol 13, 982583, 2022). Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1200313. PMID:37383614. IF:3.200(Q2/4D).

Pascual, JC, Arias, L, Soler, J. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS DRUGS. 2023; 37(6)DOI:10.1007/s40263-023-01015-6. PMID:37256484. IF:7.400(Q1/1D).

Fraguas D., Almenta Gallego D., Arques-Egea S., Gómez-Revuelta M., Sánchez-Lafuente C.G., Hernández Huerta D., Núñez Arias D., Oda Plasencia-García B., Parro Torres C., Romero-Guillena S.L., Ros Cucurul E., Alamo C.. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2023; 27(1)DOI:10.1080/13651501.2022.2064308. PMID:35792729. IF:2.900(Q2/4D).

Valli, I, Segura, AG, Verdolini, N, Garcia-Rizo, C, Berge, D, Baeza, I, Cuesta, MJ, Gonzalez-Pinto, A, Lobo, A, Martinez-Aran, A, Mezquida, G, Pina-Camacho, L, Bejarano, AR, Mas, S, McGuire, P, Bernardo, M, Vieta, E, PEPs Grp. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2023; 148(1)DOI:10.1111/acps.13546. PMID:36912272. IF:5.300(Q1/2D).